Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Albany Molecular Research AMRI

"Albany Molecular Research Inc is a contract research and manufacturing company, providing customers drug discovery, development and manufacturing services."

Recent & Breaking News (NDAQ:AMRI)

3ST Research Files Litigation Alleging Fraud and Conversion of Inventor's Intellectual Property Rights by Albany Molecular Research Inc. (AMRI)

PR Newswire September 12, 2017

Technical Snapshots for These Biotech Stocks -- Alnylam Pharma, Alexion Pharma, Albany Molecular Research, and BioCryst Pharma

PR Newswire September 8, 2017

AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR

PR Newswire August 31, 2017

20 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  August 18, 2017

Control4 Set to Join S&P SmallCap 600

PR Newswire August 17, 2017

The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Albany Molecular Research, Inc. – AMRI

GlobeNewswire July 17, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Albany Molecular Research, Inc. (AMRI)

PR Newswire July 13, 2017

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Albany Molecular Research, Inc. - AMRI

PR Newswire July 5, 2017

Lifshitz & Miller LLP Announces Investigation of Albany Molecular Research, Inc., Atwood Oceanics, Inc., CardConnect Corp., Covisint Corporation, Sajan, Inc., Whole Foods Market, Inc. and Xactly Corporation

PR Newswire July 3, 2017

AMRI Announces Early Termination of HSR Waiting Period for The Carlyle Group and GTCR's Proposed Acquisition of AMRI

PR Newswire June 29, 2017

INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Covisint Corporation and Encourages Investors to Contact the Firm for Additional Information

Business Wire June 13, 2017

The Law Offices of Vincent Wong Reminds Investors of an Investigation of Albany Molecular Research, Inc. in Connection with the Sale of the Company to GTCR LLC and The Carlyle Group

Business Wire June 13, 2017

The Law Offices of Vincent Wong Notifies Investors of an Investigation of Albany Molecular Research, Inc. in Connection with the Sale of the Company to GTCR LLC and The Carlyle Group

Business Wire June 9, 2017

WeissLaw LLP: The Proposed Acquisition of Albany Molecular Research Inc. May Not Be In the Best Interest of AMRI Shareholders

PR Newswire June 9, 2017

Harwood Feffer LLP Announces Investigation of Albany Molecular Research, Inc.

PR Newswire June 7, 2017

SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Covisint Corporation and Encourages Investors to Contact the Firm for Additional Information

Business Wire June 7, 2017

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Ominto, Inc. -- OMNT

Business Wire June 7, 2017

Albany Molecular Research, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe Investigates Merger with The Carlyle Group

Business Wire June 7, 2017

Stocks Under Scanner in the Biotech Space -- Paratek Pharma, Verastem, Alnylam Pharma, and Albany Molecular Research

PR Newswire June 7, 2017

Wall Street's M&A Chatter From June 6: Valeant-Bausch & Lomb, Albany Molecular, Horizon Pharma

Benzinga.com  June 7, 2017